U2 small nuclear RNA 20, pseudogene (RNU2-20P)

**RNU2-20P** is annotated as a *pseudogene* of the U2 small nuclear RNA family. Pseudogenes are copies of genes that generally do not produce functional transcripts or proteins due to accumulated mutations or truncations. U2 small nuclear RNAs (snRNAs), when functional, are critical non-coding RNAs involved in spliceosome assembly and pre-mRNA splicing[1][2][3][4]. However, RNU2-20P itself is not considered functional; rather, it is a non-functional genomic remnant and is not known or predicted to act as a therapeutic target, receptor, enzyme, or regulator. It does not have established biological functions, disease associations, or pharmacological relevance according to current genomic and biomedical databases. **Analysis and Clarification:** - The "20" in the name reflects its identity as the 20th annotated pseudogene in the human U2 snRNA gene family. - There are multiple U2 snRNA genes and pseudogenes; only some are functional and encode snRNAs incorporated into the spliceosome (e.g., RNU2-1, RNU2-2, sometimes previously misclassified as pseudogenes but now recognized as functional[3]). In contrast, RNU2-20P is not known to be functional; no evidence suggests it is expressed, encodes a mature RNA, or participates in splicing. - It is *not* a therapeutic target and has no known role in disease, drug interaction, or other clinically relevant processes. - The systematic name ("RNA, U2 small nuclear 20, pseudogene") and standard abbreviation (RNU2-20P) both denote pseudogene status as per official genome annotation conventions. Thus, this entry is considered non-functional, not a drug target, and its inclusion as a "target" is likely due to gene family annotation rather than biological function.

Other names

RNU2-20PRNA, U2 small nuclear 20, pseudogeneU2 snRNA pseudogene 20